FDA approves Vosevi for Hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

Source: Food and Drug Administration - July 18, 2017 Category: American Health Source Type: news